Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/69202

TitleImpact of citrate and lipid-functionalized magnetic nanoparticles in dehydropeptide supramolecular magnetogels: properties, design and drug release
Author(s)Veloso, Sérgio R S
Silva, Joana F G
Hilliou, L.
Moura, Cacilda
Coutinho, Paulo J. G.
Martins, J. A. R.
Testa-Anta, Martín
Salgueiriño, Verónica
Correa-Duarte, Miguel A
Ferreira, Paula M. T.
Castanheira, Elisabete M. S.
Keywordsmagnetic nanoparticles
magnetogels
drug delivery
Issue dateDec-2020
PublisherMDPI
JournalNanomaterials
CitationVeloso, S.R.S.; Silva, J.F.G.; Hilliou, L.; Moura, C.; Coutinho, P.J.G.; Martins, J.A.; Testa-Anta, M.; Salgueiriño, V.; Correa-Duarte, M.A.; Ferreira, P.M.T.; Castanheira, E.M.S. Impact of Citrate and Lipid-Functionalized Magnetic Nanoparticles in Dehydropeptide Supramolecular Magnetogels: Properties, Design and Drug Release. Nanomaterials 2021, 11, 16.
Abstract(s)Currently, the nanoparticle functionalization effect on supramolecular peptide-based hydrogels remains undescribed, but is expected to affect the hydrogels' self-assembly and final magnetic gel properties. Herein, two different functionalized nanoparticles: citrate-stabilized (14.4 ± 2.6 nm) and lipid-coated (8.9 ± 2.1 nm) magnetic nanoparticles, were used for the formation of dehydropeptide-based supramolecular magnetogels consisting of the ultra-short hydrogelator Cbz-L-Met-Z-ΔPhe-OH, with an assessment of their effect over gel properties. The lipid-coated nanoparticles were distributed along the hydrogel fibers, while citrate-stabilized nanoparticles were aggregated upon gelation, which resulted into a heating efficiency improvement and decrease, respectively. Further, the lipid-coated nanoparticles did not affect drug encapsulation and displayed improved drug release reproducibility compared to citrate-stabilized nanoparticles, despite the latter attaining a stronger AMF-trigger. This report points out that adsorption of nanoparticles to hydrogel fibers, which display domains that improve or do not affect drug encapsulation, can be explored as a means to optimize the development of supramolecular magnetogels to advance theranostic applications.
TypeArticle
URIhttp://hdl.handle.net/1822/69202
DOI10.3390/nano11010016
Publisher versionhttps://www.mdpi.com/2079-4991/11/1/16
Peer-Reviewedyes
AccessOpen access
Appears in Collections:PHYSICS OF QUANTUM MATERIALS AND BIONANOSTRUCTURES (2018 - ...)
CDQuim - Artigos (Papers)
IPC - Artigos em revistas científicas internacionais com arbitragem

Files in This Item:
File Description SizeFormat 
nanomaterials-11-00016-v2.pdfMain text3,8 MBAdobe PDFView/Open
Supplementary Information_Magnetogel.pdfSupplementary Information2,31 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID